Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Capra hircus skin is an allergenic extract derived from the skin or pelt of the domestic goat (*Capra hircus*). It is primarily utilized as an *in vivo* diagnostic tool in allergy testing, such as skin prick or intradermal tests, to identify individuals with hypersensitivity to goat-derived allergens. The product was approved in the United States in 1972 under BLA 102192 and is classified as a biologic. While it is also incorporated into various homeopathic formulations by distributors like DNA Labs and Dynamic Nutritional Associates, its primary clinical application is the diagnosis of allergic conditions such as allergic rhinitis, asthma, or contact dermatitis triggered by exposure to goat pelt or skin allergens.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Capra hircus skin.